The Scientist - Home

Researchers uncover the “body-snatching” tactics of fungi that flourish immediately after wildfires.

Injecting the seasonal flu vaccine directly into clumps of malignant cells recruits immune cells to confront the cancer.

Autonomous, living microrobots that seek and destroy cancer are not as futuristic as one might imagine, thanks to a fusion of robotics and synthetic biology.

New therapeutic approaches in oncology aim to manipulate or block cancer’s adaptation to treatment.

Researchers could one day use the method to deliver antibiotics to topical wounds infected by hard-to-treat masses of bacteria.

The host transcriptional signature elicited by the coronavirus appears to be less robust and lacks the induction of key antiviral genes.

The technology, tested out on patients with epilepsy who already had electrodes implanted in their brains, is currently limited to 30–50 sentences.

The machine can be run in doctor’s offices and other point-of-care settings to give rapid results.

Nine former students and faculty members who sued the institution in 2017 over its handling of sexual harassment claims will contribute a portion of the settlement to those whose careers suffered as a result.

In recent years, laboratories on the continent have ramped up genomic sequencing capabilities, offering in-country analyses rather than outsourcing the job.

Federal agencies, academic institutions, and industrial partners are joining forces to combat COVID-19 using artificial intelligence.

Citing potential worker shortages and the effects of restricted travel and social distancing, the Environmental Protection Agency announced a “sweeping suspension” of environmental regulations that some say gives companies free rein to pollute.